Friday 19th April marked a significant milestone as we celebrate the 5th anniversary of Lateral Dx’s incorporation!
Over the past five years, we’ve grown from a promising startup of 2 people in a converted office/lab to a team of 14 people delivering high quality customer focused lateral flow contract services.
As I reflect on our journey, I wanted to extend a heartfelt thank you to everyone who has been part of our journey – your support has been instrumental in reaching this milestone.
Special Acknowledgments:
Our Landlord, Ceteris (Scotland) Ltd: Thank you for providing adaptable premises that have grown with us, fitting out our labs, and facilitating access to Business Gateway services and support.
Scottish Enterprise: Your support has been invaluable, and we extend our gratitude to Ulrike Knies-Bamforth, PhD, Gemma Lee, John Penman, and Angela Crabb for their ongoing assistance.
The Lateral Dx Team: Immense thanks to our scientists and managers. Your commitment to providing exceptional service is what keeps us moving forward. I’m listing here in order of hire ; Martin Robison, Mark Steven, Lynn Allan, Alison Mackinnon, Denitsa Stoyanova, Morag Leaver, Murron Brolly, Judit Forgacs, Rowan Brolly, Finaly Campbell, Alison Walker and Steven Lamont.
Our Customers: Completing 70 diverse projects has been a journey of growth and innovation. While confidentiality keeps us from naming all, we extend a special thanks to Alcolizer Technology. Together, we developed a world-class THC test meeting Australian standards. Our thanks also to ISCA Diagnostics for our fruitful collaborations on fungal diagnostics and Robert Gordon University.
Our success is a testament to the hard work and dedication of our talented team and the trust our clients and partners place in us.
Looking Ahead:
As we move forward, Lateral Dx will continue to provide high quality contract development and manufacturing services. We’re also excited to advance our Rapid Antibody Screening (RAS) system, and with ongoing technology evaluations, we aim to stay at the forefront of rapid diagnostics.
Here’s to innovation, growth, and many more years of success!
Richard Campbell , Managing Director